D. Kayda

Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL

K. Burroughs, D. Kayda, K. Sakhuja, 2004, Cancer Gene Therapy.

Regulation of cyclin E and p27kip during mitosis in BALB/c 3T3 cells.

Y. Wang, D. Kayda, W. J. Pledger, 1995, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.

D. Kayda, K. Sakhuja, M. Kaleko, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy.

B. Trapnell, D. Kayda, M. Kaleko, 1998, Blood.

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

B. Trapnell, D. Kayda, M. Kaleko, 1993, Nature Genetics.

Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates.

D. Kayda, M. Kaleko, R. Lyons, 1999, Human gene therapy.

Optimization of the generation and propagation of gutless adenoviral vectors.

D. Kayda, K. Sakhuja, M. Kaleko, 2003, Human gene therapy.

In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.

D. Kayda, M. Kaleko, S. Connelly, 1999, Human gene therapy.

In vivo ligand-inducible regulation of gene expression in a gutless adenoviral vector system.

D. Kayda, K. Sakhuja, M. Kaleko, 2003, Human gene therapy.